These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21981382)

  • 1. Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes.
    Yoshiike Y; Yamashita S; Mizoroki T; Maeda S; Murayama M; Kimura T; Sahara N; Soeda Y; Takashima A
    Aging Cell; 2012 Feb; 11(1):51-62. PubMed ID: 21981382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
    Lomoio S; Scherini E; Necchi D
    Brain Res; 2009 Nov; 1297():198-206. PubMed ID: 19703431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.
    Puig B; Gómez-Isla T; Ribé E; Cuadrado M; Torrejón-Escribano B; Dalfó E; Ferrer I
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):491-502. PubMed ID: 15488025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
    Cente M; Filipcik P; Pevalova M; Novak M
    Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
    Opattova A; Filipcik P; Cente M; Novak M
    J Alzheimers Dis; 2013; 33(2):339-48. PubMed ID: 22936006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau--an inhibitor of deacetylase HDAC6 function.
    Perez M; Santa-Maria I; Gomez de Barreda E; Zhu X; Cuadros R; Cabrero JR; Sanchez-Madrid F; Dawson HN; Vitek MP; Perry G; Smith MA; Avila J
    J Neurochem; 2009 Jun; 109(6):1756-66. PubMed ID: 19457097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
    Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
    Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model.
    Orejana L; Barros-Miñones L; Aguirre N; Puerta E
    Exp Gerontol; 2013 Jun; 48(6):565-71. PubMed ID: 23501261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha-tocopherol on an animal model of tauopathies.
    Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S
    Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interneuronal transfer of human tau between Lamprey central neurons in situ.
    Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF
    J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
    Yue M; Hanna A; Wilson J; Roder H; Janus C
    Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
    Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
    Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
    Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
    Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.
    Luo W; Dou F; Rodina A; Chip S; Kim J; Zhao Q; Moulick K; Aguirre J; Wu N; Greengard P; Chiosis G
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9511-6. PubMed ID: 17517623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy.
    Cente M; Filipcik P; Mandakova S; Zilka N; Krajciova G; Novak M
    J Alzheimers Dis; 2009; 17(4):913-20. PubMed ID: 19542619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
    Frasier M; Walzer M; McCarthy L; Magnuson D; Lee JM; Haas C; Kahle P; Wolozin B
    Exp Neurol; 2005 Apr; 192(2):274-87. PubMed ID: 15755545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.